Maureen Smith

Maureen Smith, M.Ed., has a long history of collaboration with the healthcare system subsequent to a rare disease diagnosis in childhood. She is Chair of Cochrane’s Consumer Executive and is involved in several Cochrane projects, including co-authoring a chapter on systematic reviews for Guidelines International Network Public toolkit: Patient and Public Involvement in Guidelines. Maureen served for 12 years on the Board of Directors of the Canadian Organization for Rare Disorders and is an active member of the rare disease community in Canada and internationally. She is an enthusiastic patient partner in a number of research studies, including a co-principal investigator on the newly created INFORM RARE Network and a principal knowledge user in a decision coaching systematic review.  Maureen is a member of the Board of Directors of the Ontario Strategy for Patient Oriented Research (SPOR) Support Unit. Since the onset of the pandemic, Maureen has been keeping herself busy with citizen engagement through work with COVID Evidence Mapping and COVID-END.

Maureen spoke at 'Virtually Cochrane', a virtual event we co-hosted with Cochrane Ireland in April 2021. Watch the recording Covid and beyond: Perspectives on how Cochrane can respond to the needs of users